96 related articles for article (PubMed ID: 7557046)
1. [Diabetic neuropathy. Current concepts on etiopathogenesis, diagnosis, and treatment].
Zorrilla Hernández E; Frati Munari A; Lozano Castañeda O; Villalpando Hernández S; Boulton AJ
Gac Med Mex; 1994; 130(1):18-25. PubMed ID: 7557046
[TBL] [Abstract][Full Text] [Related]
2. [Diabetic somatic polyneuropathy. Pathogenesis, clinical manifestations and therapeutic concepts].
Hilz MJ; Marthol H; Neundörfer B
Fortschr Neurol Psychiatr; 2000 Jun; 68(6):278-88. PubMed ID: 10923253
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration.
Nicolucci A; Carinci F; Cavaliere D; Scorpiglione N; Belfiglio M; Labbrozzi D; Mari E; Benedetti MM; Tognoni G; Liberati A
Diabet Med; 1996 Dec; 13(12):1017-26. PubMed ID: 8973882
[TBL] [Abstract][Full Text] [Related]
4. Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients.
Uluc K; Isak B; Borucu D; Temucin CM; Cetinkaya Y; Koytak PK; Tanridag T; Us O
Clin Neurophysiol; 2008 Apr; 119(4):880-5. PubMed ID: 18291716
[TBL] [Abstract][Full Text] [Related]
5. Diabetic peripheral neuropathy.
Das AK; Vijayaraghavan MV
J Assoc Physicians India; 1991 Oct; 39(10):760-3. PubMed ID: 1816202
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.
Ho EC; Lam KS; Chen YS; Yip JC; Arvindakshan M; Yamagishi S; Yagihashi S; Oates PJ; Ellery CA; Chung SS; Chung SK
Diabetes; 2006 Jul; 55(7):1946-53. PubMed ID: 16804062
[TBL] [Abstract][Full Text] [Related]
7. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.
Ramirez MA; Borja NL
Pharmacotherapy; 2008 May; 28(5):646-55. PubMed ID: 18447661
[TBL] [Abstract][Full Text] [Related]
8. [Etiopathogenesis of diabetic neuropathy].
Gryz EA; Galicka-Latała D; Szczudlik A; Sieradzki J
Przegl Lek; 2000; 57(12):727-31. PubMed ID: 11398597
[TBL] [Abstract][Full Text] [Related]
9. [Treatment with an aldose reductase inhibitor in peripheral neuropathy in elderly diabetic patients].
Terranova R; Luca S
Minerva Med; 1993 Sep; 84(9):461-6. PubMed ID: 8247317
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and therapy of diabetic polyneuropathy].
Stracke H; Federlin K
Z Gesamte Inn Med; 1993 May; 48(5):259-61. PubMed ID: 8517070
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte sorbitol level as a predictor of the efficacy of epalrestat treatment for diabetic peripheral polyneuropathy.
Ando H; Takamura T; Nagai Y; Kaneko S;
J Diabetes Complications; 2006; 20(6):367-70. PubMed ID: 17070440
[TBL] [Abstract][Full Text] [Related]
12. Diabetic peripheral neuropathy.
Younger DS; Rosoklija G; Hays AP
Semin Neurol; 1998; 18(1):95-104. PubMed ID: 9562671
[TBL] [Abstract][Full Text] [Related]
13. Diabetic neuropathy: therapies on the horizon.
Mahmood D; Singh BK; Akhtar M
J Pharm Pharmacol; 2009 Sep; 61(9):1137-45. PubMed ID: 19703362
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of diabetic neuropathy].
Frati-Munari AC; Ariza-Andraca CR
Gac Med Mex; 1998; 134(1):85-92. PubMed ID: 9658700
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of peripheral neuropathy in newly diagnosed patients with non-insulin-dependent diabetes mellitus.
Weerasuriya N; Siribaddana S; Wijeweera I; Dissanayeka A; Wijesekera J; Fernando DJ
Ceylon Med J; 1998 Mar; 43(1):19-21. PubMed ID: 9624839
[TBL] [Abstract][Full Text] [Related]
16. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
Jarmuzewska EA; Ghidoni A
Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathy in patients with diabetic foot ulcers: clinical and nerve conduction study.
Kiziltan ME; Gunduz A; Kiziltan G; Akalin MA; Uzun N
J Neurol Sci; 2007 Jul; 258(1-2):75-9. PubMed ID: 17399742
[TBL] [Abstract][Full Text] [Related]
18. [Diabetic neuropathy--a clinical review].
Nøkleby K; Berg TJ
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1646-9. PubMed ID: 15976830
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and investigation of diabetic somatic peripheral neuropathy.
Thomas PK
Clin Neurosci; 1997; 4(6):341-5. PubMed ID: 9358978
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of diabetic neuropathy].
Jasik M
Przegl Lek; 2003; 60(3):167-9. PubMed ID: 14575019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
